Adjuvant chemotherapy in older women with early-stage breast cancer. - Test2 - elhamkhani - TriplyDB

Adjuvant chemotherapy in older women with early-stage breast cancer.

Adjuvant chemotherapy in older women with early-stage breast cancer.

http://www.wikidata.org/entity/Q34858284

about

Practices and impact of primary outcome adjustment in randomized controlled trials: meta-epidemiologic study Therapeutic usefulness of postoperative adjuvant chemotherapy with Tegafur-Uracil (UFT) in patients with breast cancer: focus on the results of clinical studies in Japan Cardiac toxicity of trastuzumab in elderly patients with breast cancer Adjuvant systemic therapy in older women with breast cancer Adjuvant medical treatment for breast cancer in elderly and old women Early-Stage Breast Cancer in the Elderly: Confronting an Old Clinical Problem Management of early breast cancer in older women: from screening to treatment Current approaches in treatment of triple-negative breast cancer Screening mammography in older women: a review Adjuvant chemotherapy for early female breast cancer: a systematic review of the evidence for the 2014 Cancer Care Ontario systemic therapy guideline Current treatment of early breast cancer: adjuvant and neoadjuvant therapy Adjuvant Systemic Therapy in Older Breast Cancer Women: Can We Optimize the Level of Care?Optimal management of breast cancer in the elderly patient: current perspectives Adjuvant treatment for older women with invasive breast cancer Specific Aspects of Breast Cancer Therapy of Elderly Women Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 Preliminary Development and Evaluation of an Algorithm to Identify Breast Cancer Chemotherapy Toxicities Using Electronic Medical Records and Administrative Data.The Treatment of Primary Breast Cancer in Older Women With Adjuvant Therapy: A Retrospective Analysis of Data From Over 3000 Patients From the PATH Biobank, With Two-Year Follow-up Chemotherapy use and risk of bone marrow suppression in a large population-based cohort of older women with breast and ovarian cancer.A comparison of toxicity profiles between the lower and standard dose capecitabine in breast cancer: a systematic review and meta-analysis.Final results of a phase I/II pilot study of capecitabine with or without vinorelbine after sequential dose-dense epirubicin and paclitaxel in high-risk early breast cancer Acceptance of oral chemotherapy in breast cancer patients - a survey study.Adherence and persistence with oral adjuvant chemotherapy in older women with early-stage breast cancer in CALGB 49907: adherence companion study 60104 Using ePrognosis to estimate 2-year all-cause mortality in older women with breast cancer: Cancer and Leukemia Group B (CALGB) 49907 and 369901 (Alliance A151503)Triple-negative breast cancer: role of specific chemotherapy agents Senior adult oncology: three cases of advanced cancer in patients of advanced age The value of observational cohort studies for cancer drugs.Breast cancer adjuvant chemotherapy decisions in older women: the role of patient preference and interactions with physicians.Hospital-based health care use correlates with incidence of adverse events among elderly Medicare patients treated in adjuvant chemotherapy trials (Alliance 70802).Adjuvant chemotherapy in breast cancer: To use or not to use, the anthracyclines Designing therapeutic clinical trials for older and frail adults with cancer: U13 conference recommendations Cognitive effects of cancer systemic therapy: implications for the care of older patients and survivors.Comorbidity, chemotherapy toxicity, and outcomes among older women receiving adjuvant chemotherapy for breast cancer on a clinical trial: CALGB 49907 and CALGB 361004 (alliance)Older women, breast cancer, and social support.Biological characterization and selection criteria of adjuvant chemotherapy for early breast cancer: experience from the Italian observational NEMESI study.Geriatric Oncology Research in the Cooperative Groups: A Report of a SIOG Special Meeting.Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Cancer physicians' attitude towards treatment of the elderly cancer patient in a developed Asian country.SWOG S0221: a phase III trial comparing chemotherapy schedules in high-risk early-stage breast cancer.Quality of life of older patients with early-stage breast cancer receiving adjuvant chemotherapy: a companion study to cancer and leukemia group B 49907.

P2860

Q24289045-C4680DCF-0DC2-4B9E-B12B-5D8AC8D80C3B Q24633384-AA55BF85-A738-4CC3-B724-2F5FC9192146 Q26741182-6CD8FF6C-8527-47BC-8B19-1AF36707D010 Q26741523-697E7C2D-8411-432D-A63C-A8C273415D15 Q26749063-558DC707-9A29-438F-9CCF-25D3B9CF8D6E Q26782584-A5F6EDD7-E892-428D-89AC-B2CC67652652 Q26799695-ADFCC65F-29D9-4168-883E-CC5F180DFEBC Q26801549-640950CF-1ED9-44AC-8E55-BA8E64610FB5 Q26829839-22BC6C5F-DFA5-4F78-86D2-F0BB6580D970 Q26853619-E4B156D7-0AE2-4668-AC40-E926F7F67D78 Q27011658-86305ED5-1E64-43AF-A0E0-92678B24268D Q27025860-CEC845D6-36EA-4591-8C73-37932D38AFF1 Q27690879-4A8BBD5A-D1D0-4D21-B52B-1EA5B0C46B07 Q28066744-4DA29681-7FF1-48A9-9810-2D0B451C9DDC Q28079170-5B059783-4695-42E6-8911-929BF72AAB7F Q30543788-C0F4966E-998F-421B-BCEB-F8AC40F71395 Q30845285-A8CACFC2-632A-4875-8115-A14DA5228C54 Q30993896-27E6BE79-DC4C-416A-9D70-DC204D8852E2 Q33389009-C9C62369-3E09-44F5-A61F-98454FA2D3FD Q33430813-F4093658-AED8-413F-A8F7-745892CA9966 Q33659628-8A351645-53F7-4D3F-9CBA-645B8A76A8B5 Q33870472-88D8D27B-2AB7-4704-965D-5BBD143959FB Q33897610-DF63C104-13D4-434C-BEF7-2C3AA1F9ED19 Q33900866-6DF2BD73-E511-4D0B-BC58-DE2192F058FB Q33900930-868BF56F-3135-4622-B6A7-7481A28B038E Q33928825-13361CFD-A0AD-4DE4-A7C9-29B2F0C4F7BD Q33973945-9D62DC3F-42A9-4E3D-B9BD-146DB0C2544F Q33990818-41D0E173-2D5F-424F-AAD1-6DD2A2238016 Q33992552-1469E3A3-324F-4D97-B263-31A545E51264 Q34023749-94B3A3E3-29BF-4FDA-B77F-E8E52ECD1CB1 Q34031134-A1985500-29FE-4AA2-88A1-DFB1222525DE Q34031141-6C728193-6679-424B-8E98-AD063E5F5600 Q34168190-6291A0B1-63D2-4D2B-B506-366F96734827 Q34222488-5EF8E60C-780D-473D-8CAB-EED265AD1F46 Q34294414-E5EB6C08-0C84-4DF5-ACC7-A88CBC53E536 Q34460029-1E893375-5829-4A26-B303-C95275F513BE Q34655579-C269CC2E-D1B4-42D4-AC54-3F347AEB3476 Q34670408-8633DF16-2896-4186-93AB-9CD2D9527C68 Q34716590-C53A7C77-8308-44C0-8C01-2269391033C9 Q34743448-AD6591D8-8175-409C-9F19-2D3CC6A0FDAD

P2860

Adjuvant chemotherapy in older women with early-stage breast cancer.

http://www.wikidata.org/entity/Q34858284

description

2009 nî lūn-bûn

@nan

2009 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

name

Adjuvant chemotherapy in older women with early-stage breast cancer.

@ast

Adjuvant chemotherapy in older women with early-stage breast cancer.

@en

Adjuvant chemotherapy in older women with early-stage breast cancer.

@nl

type

label

Adjuvant chemotherapy in older women with early-stage breast cancer.

@ast

Adjuvant chemotherapy in older women with early-stage breast cancer.

@en

Adjuvant chemotherapy in older women with early-stage breast cancer.

@nl

prefLabel

Adjuvant chemotherapy in older women with early-stage breast cancer.

@ast

Adjuvant chemotherapy in older women with early-stage breast cancer.

@en

Adjuvant chemotherapy in older women with early-stage breast cancer.

@nl

P1433

Q34858284-B4D800B4-5D15-4AD5-859B-3ED2C6542FAE

P1476

Q34858284-4FE6595C-1713-4505-BF43-9E8EE5114A6B

P2093

Q34858284-005410A6-EAA3-44D5-B480-B0F1F5EA2DDB

Q34858284-1193E239-53B9-4E14-9AAB-05FC5400EC23

Q34858284-15606ED2-CC25-422A-B62F-05BBB6F4D7BB

Q34858284-3696CF00-6ECF-454C-A33F-A9C803F689D6

Q34858284-40FED66F-A987-4D84-8914-749DAE0C9349

Q34858284-49D5EEF7-A170-43F9-8461-53B9DDB837F1

Q34858284-55654104-FA89-44C2-8874-0A071A07959D

Q34858284-562E15DC-0B8B-4875-B6D4-6E40A06E8BAF

Q34858284-5E2FE9A1-EFF1-4488-BE5D-DC63F5BB0217

Q34858284-71A253EA-C556-4C04-B999-AEF5CC2C27A7

P2860

Q34858284-02DDFE6E-2B81-4FB3-90F8-194FCCF14EFF

Q34858284-0B008B05-B72E-48AB-B269-E969AC8EA465

Q34858284-18566007-771F-4675-B8A4-A62A3A123DB3

Q34858284-2009409F-B953-4CB1-A6AC-2F3679AAEB5D

Q34858284-26E88175-199B-44F9-B2FF-C2DA9E9946EE

Q34858284-2B39FD71-E27F-4E1F-8565-81A67EC58AF4

Q34858284-336A3B43-3CAD-4DA5-9BD5-ACFA100B9CEE

Q34858284-3393F5A7-598F-40B5-8261-7F51C4D54A31

Q34858284-370F1F35-18BB-4864-A575-FB94B3F90CCB

Q34858284-56381E54-694D-40B2-A3CF-E4B0E8795C95

P304

Q34858284-62152697-CB53-4AE2-9C05-8E76D2AF579D

P31

Q34858284-35808FD2-7A11-4C76-981F-30424EC1FD4C

P356

Q34858284-8E4EB640-09B0-4D6C-A989-710345322252

P407

Q34858284-E7CA7572-533C-4595-A760-2154F762FC67

P433

Q34858284-76FC8444-7E0E-43B0-88B6-D0154A19FBB4

P478

Q34858284-6D9E99A1-67F7-4BF9-908F-71B426118C68

P50

Q34858284-1DF6747A-B656-49C6-92D8-4A409305E481

Q34858284-ADFDBFB5-9F4C-441F-8B2E-567FD7BDCBB5

P577

Q34858284-F18C169B-4FD9-4B32-BC52-4434FC2372DF

P5875

Q34858284-3C7824F8-B136-443E-9617-8DD272B5348F

P698

Q34858284-01EAF749-43D2-42A2-AF97-CAB752CDB80C

P921

Q34858284-CFFE07C5-EE99-496E-9A5B-35B4CF37AA91

P932

Q34858284-B8E3DAC3-F30D-48B3-9C2B-D896A05C80FC

P356

P1433

The New England Journal of Medicine

P1476

Adjuvant chemotherapy in older women with early-stage breast cancer.

@en

P2093

Ahmad A Mahmood

http://www.w3.org/2001/XMLSchema#string

Alice B Kornblith

http://www.w3.org/2001/XMLSchema#string

Ann H Partridge

http://www.w3.org/2001/XMLSchema#string

Ann M Mauer

http://www.w3.org/2001/XMLSchema#string

Barbara A Parker

http://www.w3.org/2001/XMLSchema#string

CALGB Investigators

http://www.w3.org/2001/XMLSchema#string

Clifford A Hudis

http://www.w3.org/2001/XMLSchema#string

Constance T Cirrincione

http://www.w3.org/2001/XMLSchema#string

Debjani Grenier

http://www.w3.org/2001/XMLSchema#string

Donald A Berry

http://www.w3.org/2001/XMLSchema#string

P2860

Differences in management of older women influence breast cancer survival: results from a population-based database in Sweden

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Tamoxifen and chemotherapy for axillary node-negative, estrogen receptor-negative breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-23.

Clinical status of capecitabine in the treatment of breast cancer.

Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer.

Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older.

Effect of screening and adjuvant therapy on mortality from breast cancer.

Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer.

Compliance with consensus recommendations for systemic therapy is associated with improved survival of women with node-negative breast cancer.

Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer.

P304

2055-2065

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA0810266

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

360

http://www.w3.org/2001/XMLSchema#string

P50

Antonio C. Wolff

P577

2009-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24424967

http://www.w3.org/2001/XMLSchema#string

P698

19439741

http://www.w3.org/2001/XMLSchema#string

P921

P932

3082436

http://www.w3.org/2001/XMLSchema#string